For instance, there were research results showing that TRIB2 was highly expressed in small cell lung cancer, and its overexpression could promote cisplatin resistance by reducing the level of enhancer-binding protein α in small cell lung cancer cells [14]. Here, TRIB2 is linked to small cell lung carcinoma.